Table 4.
HPV-positive and HPV-negative in a linear mixed model of mean Health Related Quality of Life (QLQ C30) across end of treatment, 1 months and 3 months post treatment.
| Variable | β Statistic | p-Value | 95% CI | |
|---|---|---|---|---|
| Total HRQOL score * | 2.63 | 0.50 | 0.26, 0.68 | |
| Global Health * | 2.83 | 0.53 | −6.17, 11.83 | |
| Functional Outcomes * | ||||
| Role functioning | −2.61 | 0.70 | 16.23, 10.99 | |
| Physical Functioning | 2.91 | 0.54 | −6.54, 12.37 | |
| Emotional Functioning | 0.47 | 0.91 | −7.50, 8.43 | |
| Cognitive Functioning | −14.34 | <0.01 | −75, −5.04 | |
| Social Functioning | −3.03 | 0.58 | −13.81, 7.77 | |
| Symptom Scales # | ||||
| Fatigue | −3.44 | 0.53 | −14.06, 7.18 | |
| Nausea & Vomiting | −5.69 | 0.33 | −17.94, 6.56 | |
| Pain | 9.59 | 0.11 | −2.26, 21.44 | |
| Dyspnea | −5.69 | 0.21 | −14.57, 3.20 | |
| Insomnia | 0.82 | 0.89 | −11.27, 12.91 | |
| Appetite Loss | −10.91 | 0.19 | −27.33, 5.50 | |
| Constipation | 4.28 | 0.47 | −7.42, 15.99 | |
| Diarrhea | −2.99 | 0.48 | −11.29, 5.29 | |
| Financial difficulties | 2.48 | 0.75 | −12.73, 17.69 | |
Abbreviations: HPV = Human papillomavirus; CI = confidence interval; HRQOL = Health-Related Quality of Life Questionnaire (QLQ-C30). * Higher score is better. # Lower score is better.